Riken Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko The Japanese Ministry of Health, Labor, and Welfare has approved AmoyDx's PLC Panel for use in identifying NSCLC patients with MET exon 14 skipping alterations. Opossum Change Researchers from Riken have used CRISPR to edit marsupial genomes, as Technology Review reports. AmoyDx PCR Panel Receives Japanese Approval as CDx for Non-Small Cell Lung Cancer Therapies The Japanese MHLW approved the real-time PCR-based test as a CDx to detect four driver genes for nine associated NSCLC targeted therapies. Coronary Artery Disease Loci Identified in Japanese GWAS, Trans-Ancestry Meta-Analysis Researchers found ancestry-specific risk variants and developed a better polygenic risk score based on a GWAS and subsequent meta-analysis. Nature Papers Uncover Disease Susceptibility Loci in Japanese Population, Transfer RNA Modification Profiling In Nature this week: genome-wide association study of 42 diseases among Japanese population, transfer RNA modifications, and more. Mar 16, 2020 Chan Zuckerberg Initiative Awards $400K in Funding for Asian Immune Cell Atlas Project Nov 22, 2019 Breast Cancer GWAS Leads to New Risk Loci in Japanese Population Nov 12, 2019 Supercentenarians Have Increased Levels of Cytotoxic CD4 T Cells Feb 5, 2018 Genetic Analysis Reveals Relationship Between Clinical Measurements, Disease Traits Oct 23, 2017 Human Cell Atlas Consortium Aims to Complete First Draft by 2022 Premium Apr 17, 2017 New Variants Linked to Atrial Fibrillation Risk Mar 1, 2017 Atlas of Long Non-Coding RNAs Suggests Many Are Functional Oct 28, 2016 Enabled by Single-Cell Genomics, International Team Launches Human Cell Atlas Initiative Premium Apr 11, 2016 Liver Cancer Marked by Both Noncoding, Structural Mutations, Study Finds Oct 21, 2015 Researchers Link Loci Near Three Genes to Peripheral Artery Disease Risk Mar 31, 2015 Riken-Genesis to Offer Advaita Gene Pathway Analysis Platform in Japan Dec 18, 2014 Riken Team Uses Phenotypic, Gene Expression Analysis to Elucidate Bacterial Drug Resistance Mar 27, 2014 Genomics in the Journals: Mar 27, 2014 Mar 14, 2014 New Zenbu Browser Improves Visualization, Analysis for Large-Scale Transcriptome Studies Premium Sep 17, 2013 Riken Teams with Indian Research Centers Aug 8, 2013 Riken, DNAForm Team Develops 'Eprobes' for Combined Real-Time PCR, Melt Curve Analysis Premium Jul 17, 2013 Mayo Team Forging Ahead With Promising Markers for Predicting Preventive Breast Cancer Therapy Response Premium May 7, 2013 Researchers Present Streamlined Poly-A Tailing-based Strategy for Single-cell RNA-sequencing Premium Apr 29, 2013 New Genomes Serve as Source of Information on Turtle Evolution, Adaptation Jun 28, 2012 IP Watch: Roche, Sequenom, Rubicon, NetBio, Riken, DNAForm, Cepheid and More Win US Patents Premium Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.